PPIDT00269
Drug Information
| Name | Simoctocog alfa |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB09108 |
| Type | biotech |
| Indication | Simoctocog alfa is a recombinant antihemophilic factor [blood coagulation factor VIII (Factor VIII) indicated in adults and children with Hemophilia A for the on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. It is not indicated for the treatment of von Willebrand Disease.[L40985, L40990] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Intravenous |
1000 IU
|
| Injection, powder, for solution | Intravenous |
1500 IU
|
| Injection, powder, for solution | Intravenous |
2000 IU
|
| Injection, powder, for solution | Intravenous |
2500 IU
|
| Injection, powder, for solution | Intravenous |
3000 IU
|
| Injection, powder, for solution | Intravenous |
4000 IU
|
| Kit | Intravenous |
1000 [iU]/2.5mL
|
| Kit | Intravenous |
1500 [iU]/2.5mL
|
| Kit | Intravenous |
2000 [iU]/2.5mL
|
| Kit | Intravenous |
250 [iU]/2.5mL
|
| Kit | Intravenous |
2500 [iU]/2.5mL
|
| Kit | Intravenous |
3000 [iU]/2.5mL
|
| Kit | Intravenous |
4000 [iU]/2.5mL
|
| Kit | Intravenous |
500 [iU]/2.5mL
|
| Kit; powder, for solution | Intravenous |
|
| Injection, powder, lyophilized, for solution | Intravenous |
1000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
2000 IU
|
| Injection, powder, for solution | Intravenous |
|
| Injection, powder, for solution | Intravenous |
250 IU
|
| Injection, powder, for solution | Intravenous |
500 IU
|